Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on January 29, 2009, regarding an event that occurred on January 26, 2009. The company is a Delaware corporation focused on neural stem cell technology.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a specific corporate event rather than a financial statement.
Material Changes
On January 26, 2009, Neuralstem, Inc. received an Official Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application number 10/047,352. The patent covers technology for "Stable Neural Stem Cell Lines," which allows for the immortalization of any human neural stem cell to ensure robust and long-lasting growth.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes standard legal disclaimers stating that the information is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the exact scope and claims of US Patent Application 10/047,352 via the USPTO database.
- Confirm the commercial viability and timeline for products utilizing the "Stable Neural Stem Cell Lines" technology.
- Review the attached press release (Exhibit 99.1) for additional details on the patent's strategic importance.
- Check subsequent filings for any financial impact or licensing agreements related to this patent.